Home / Market Reports / Medical Care
/ Global Tuberculosis (TB) Detection Market Growth (Status and Outlook) 2023-2029
Global Tuberculosis (TB) Detection Market Growth (Status and Outlook) 2023-2029
-
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
Provide comprehensive and accurate analysis and reports according to your exact requirements
Tuberculosis (TB) is a chronic infection caused by the bacterium tuberculosis (TB).Tuberculous bacterium invades human body all sorts of organs possibly, but basically encroach lung, call tuberculosis disease.
Tuberculosis (TB) is a chronic and slow - onset infectious disease in young people.The incubation period is 4 to 8 weeks.Of these, 80% occur in the lungs, and other areas (cervical lymph, meninges, peritoneum, intestine, skin, bone) may also be secondary to infection.Transmission of respiratory tract from person to person is the main mode of transmission.Infection source is the person that contacts the tuberculosis that discharges bacterium.With the spread of environmental pollution and AIDS, the incidence of TB is becoming more and more intense.In addition to a few cases of rapid onset, clinical more chronic process.There are often low fever, fatigue and other systemic symptoms and respiratory symptoms such as cough, hemoptysis.
LPI (LP Information)' newest research report, the “Tuberculosis (TB) Detection Industry Forecast” looks at past sales and reviews total world Tuberculosis (TB) Detection sales in 2022, providing a comprehensive analysis by region and market sector of projected Tuberculosis (TB) Detection sales for 2023 through 2029. With Tuberculosis (TB) Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tuberculosis (TB) Detection industry.
This Insight Report provides a comprehensive analysis of the global Tuberculosis (TB) Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tuberculosis (TB) Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tuberculosis (TB) Detection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tuberculosis (TB) Detection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tuberculosis (TB) Detection.
The global Tuberculosis (TB) Detection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
In Southeast Asia, Tuberculosis (TB) Detection key players include Danaher, Roche, Thermal Fisher, Abbott, etc.
Indonesia is the largest market, with a share over 20%, followed by Philippines, and Myanmar, both have a share about 30 percent.
In terms of product, Bacterial Culture Test is the largest segment, with a share about 50%. And in terms of application, the largest application is Hospital, followed by Clinic, Research Institution, etc.
This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis (TB) Detection market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Bacterial Culture Test
Tuberculin Test
Rapid Molecular Diagnosis
Other
Segmentation by application
Hospital
Clinic
Research Institution
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Danaher
Roche
Thermal Fisher
Abbott
Oxford Immunotec International
Qiagen
Hologic
Hain Lifescience
Epistem
Creative Diagnostics